Trial intelligence / Profile preview

KW-2246 for Breakthrough Cancer Pain

NCT00684632Phase 3Completed

Sponsor
Kyowa Kirin
Start
Mar 2008
Primary completion
Apr 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fentanyl in breakthrough pain, sponsored by Kyowa Kirin. Started Mar 2008; status: completed.

02

Drugs

fentanyl
03

Conditions

breakthrough pain

Beyond the preview

Go deeper on NCT00684632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00684632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call